Thermo Fisher Scientific Inc ($TMO) Stock Forecast: Down 5.2% Today

What is Thermo Fisher Scientific Inc?

Thermo Fisher Scientific Inc. (NYSE: TMO) is a leading company in the medical research industry, known for its innovative solutions and strong financial performance. Today, the stock experienced a significant bearish movement in the market.

Why is Thermo Fisher Scientific Inc going down?

TMO stock is down 5.2% on Feb 12, 2026 16:07

• Varma Mutual Pension Insurance Co and Cornerstone Investment Partners LLC increased their holdings in TMO, showing confidence in the company's future prospects.
• ING Groep NV and Atria Investments Inc reduced their stakes in TMO, possibly due to profit-taking or portfolio rebalancing.
• The initiation of a $5 billion stock repurchase plan by Thermo Fisher Scientific may have influenced market sentiment, signaling management's belief in the company's undervaluation.
• Despite the mixed institutional activity and insider sales, analysts maintain a "Moderate Buy" rating for TMO, with an average price target of $633.68, reflecting positive quarterly earnings and growth potential.

TMO Price Chart

TMO Technical Analysis

TMO News

Varma Mutual Pension Insurance Co Increases Holdings in Thermo Fisher Scientific Inc. $TMO

Varma Mutual Pension Insurance Co recently increased its stake in Thermo Fisher Scientific (NYSE:TMO) by 8.6% during the third quarter, now owning 65,917 shares valued at $31,971,000. Other institutional investors have also adjusted their holdings in the medical research company. Thermo Fisher Scientific reported strong earnings, exceeding analyst expectations, and has authorized a $5.00 billion stock repurchase plan, signaling confidence from its board of directors.

https://www.marketbeat.com/instant-alerts/filing-varma-mutual-pension-insurance-co-increases-holdings-in-thermo-fisher-scientific-inc-tmo-2026-02-12/

ING Groep NV Has $15.53 Million Position in Thermo Fisher Scientific Inc. $TMO

ING Groep NV significantly reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 80.0% in the third quarter, bringing its holding to $15.53 million. Despite institutional selling, analysts generally maintain a "Moderate Buy" rating for the stock with an average target price of $633.68. Thermo Fisher Scientific also initiated a $5.00 billion stock buyback program, indicating management's belief that shares are undervalued.

https://www.marketbeat.com/instant-alerts/filing-ing-groep-nv-has-1553-million-position-in-thermo-fisher-scientific-inc-tmo-2026-02-12/

There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings

Bio-Techne Corporation (NASDAQ:TECH) recently reported earnings that were weaker than expected due to a significant US$155m expense classified as an "unusual item." Simply Wall St analysis suggests that despite the statutory profit being lower, the underlying earnings potential of the company might be stronger than it appears, as these unusual items are typically one-off. Investors are encouraged to look beyond the reported profit and consider other factors like margins, growth forecasts, and return on investment while being aware of the associated risks.

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/there-may-be-some-bright-spots-in-bio-technes-nasdaqtech-ear

Cornerstone Investment Partners LLC Makes New Investment in Thermo Fisher Scientific Inc. $TMO

Cornerstone Investment Partners LLC has made a significant new investment in Thermo Fisher Scientific Inc. (NYSE:TMO), purchasing over 85,000 shares valued at approximately $41.39 million. This move is part of broader institutional activity, with major firms like Vanguard and Norges Bank also adjusting their positions, while company insiders have recently sold shares. Analysts maintain a "Moderate Buy" rating for TMO, with an average price target of $633.68, following positive quarterly earnings and a $5 billion share buyback authorization.

https://www.marketbeat.com/instant-alerts/filing-cornerstone-investment-partners-llc-makes-new-investment-in-thermo-fisher-scientific-inc-tmo-2026-02-12/

Atria Investments Inc Decreases Holdings in Thermo Fisher Scientific Inc. $TMO

Atria Investments Inc significantly reduced its stake in Thermo Fisher Scientific Inc. by 31.6% in the third quarter, selling 15,333 shares and retaining 33,246 shares valued at $16.125 million. Despite this reduction, institutional investors collectively own 89.23% of the company's stock, and analysts maintain a "Moderate Buy" rating with a consensus price target of $633.68. Recent insider sales include transactions by COO Michel Lagarde and EVP Michael D. Shafer, totaling over $25 million in shares sold.

https://www.marketbeat.com/instant-alerts/filing-atria-investments-inc-decreases-holdings-in-thermo-fisher-scientific-inc-tmo-2026-02-12/

Trending Today

Dogecoin ($DOGE) Crypto Forecast: Down 7.8% Today

Hims & Hers Health Inc. ($HIMS) Stock Forecast: Down 5.3% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Up 5.3% Today

Welltower Inc. ($WELL) Stock Forecast: Down 0.9% Today

Tapestry Inc. ($TPR) Stock Forecast: Down 5.0% Today

Booking Holdings Inc. ($BKNG) Stock Forecast: Up 7.8% Today

Intellia Therapeutics, Inc. ($NTLA) Stock Forecast: Down 5.1% Today

Corning Incorporated ($GLW) Stock Forecast: Down 8.0% Today

FuelCell Energy ($FCEL) Stock Forecast: Down 6.5% Today

Newell Brands Inc. ($NWL) Stock Forecast: Down 5.3% Today

Thermo Fisher Scientific Inc Price History

01.07.2025 - TMO Stock was down 5.1%

• The decline in Thermo Fisher Scientific's stock today may be linked to the adoption of a bearish stance by influential investors, as reflected in options trading activities.
• While TMO has consistently outperformed the market in the long run, short-term market sentiment and investor behavior can impact daily fluctuations.
• Investors might be capitalizing on gains or adjusting their positions in response to prevailing market conditions or internal company developments, influencing the stock's downward trajectory today.
• It is crucial for investors to assess both TMO's long-term growth prospects and the short-term market dynamics to make well-informed investment choices.

29.00.2026 - TMO Stock was down 5.2%

• Thermo Fisher (TMO) experienced a bearish movement despite reporting better-than-expected Q4 CY2025 results, with revenue surpassing analyst estimates and strong performance in its Life Sciences Solutions segment.
• The stock might have faced downward pressure due to profit-taking by investors following the immediate stock increase post-earnings report.
• The overall market sentiment could have been influenced by broader market conditions or sector rotation, leading to the bearish movement in TMO's stock price today.
• It's possible that investors were expecting even stronger guidance or future outlook from the company, causing some disappointment and resulting in the bearish market movement.

30.08.2025 - TMO Stock was up 3.8%

• The positive market response to TMO's bond offering suggests investor confidence in the company's financial stability.
• The continued bullish interest from financial institutions and traders signals strong belief in Thermo Fisher Scientific's growth potential.
• Overall, TMO's bullish performance today could be linked to the successful bond offering and positive market sentiment.

02.00.2026 - TMO Stock was up 2.2%

• The global single-use bioprocessing products market is expected to witness substantial growth, with Thermo Fisher Scientific Inc. playing a significant role in the industry's advancement, contributing to the optimistic market trends.
• Noteworthy increases in stakes by Allspring Global Investments Holdings LLC and Ninety One UK Ltd in TMO reflect a growing confidence in the company's future, potentially influencing a rise in the stock's value.
• Despite recent significant insider sales, the company's impressive quarterly earnings report surpassing expectations, coupled with the initiation of a new stock buyback program and quarterly dividend declaration, have likely bolstered investor trust in TMO.
• The collective institutional interest and portfolio adjustments by different investment entities indicate a favorable outlook for TMO, aligning with the current bullish market movement.

18.11.2025 - TMO Stock was down 2.4%

• The decline in TMO stock may be linked to profit-taking by institutional investors actively trading the stock.
• Despite positive updates on strong quarterly earnings and a $5 billion share buyback program, concerns arose among investors due to insider selling by the CEO and COO, potentially contributing to the stock's downward trend.
• Weak performance by West Pharmaceutical Services (WST) in the healthcare sector could have also impacted investor sentiment towards TMO, as some may have shifted away from underperforming healthcare stocks.
• In sum, today's bearish movement in TMO stock seems influenced by profit-taking, insider selling concerns, and broader sector trends affecting investor outlook.

23.06.2025 - TMO Stock was up 11.9%

• Financial giants and deep-pocketed investors have shown a bullish sentiment towards Thermo Fisher Scientific, with a majority of traders leaning towards a positive outlook on the stock.
• The upcoming second-quarter earnings report, especially focusing on the Analytical Instruments segment, has generated optimism and interest among investors.
• The increased bullish options trading activity suggests that market players are anticipating positive growth and performance from Thermo Fisher Scientific in the near future.

23.06.2025 - TMO Stock was up 12.4%

• Q2 earnings and revenues of Thermo Fisher Scientific exceeded expectations, propelled by successful product launches and robust segment growth, resulting in a notable increase in the stock price.
• Notable bullish sentiment was observed in the options trends for TMO, with a majority of traders expressing optimism about the stock.
• Investors are placing emphasis on the growth prospects of Thermo Fisher's Analytical Instruments segment, foreseeing its positive impact on performance in the upcoming quarters.
• The optimistic outlook from major investors towards TMO, reflected through options activity, likely played a role in the stock's favorable market trajectory today.

12.01.2026 - TMO Stock was down 5.2%

• Varma Mutual Pension Insurance Co and Cornerstone Investment Partners LLC increased their holdings in TMO, showing confidence in the company's future prospects.
• ING Groep NV and Atria Investments Inc reduced their stakes in TMO, possibly due to profit-taking or portfolio rebalancing.
• The initiation of a $5 billion stock repurchase plan by Thermo Fisher Scientific may have influenced market sentiment, signaling management's belief in the company's undervaluation.
• Despite the mixed institutional activity and insider sales, analysts maintain a "Moderate Buy" rating for TMO, with an average price target of $633.68, reflecting positive quarterly earnings and growth potential.

22.06.2025 - TMO Stock was up 5.5%

• Thermo Fisher Scientific is set to report its Q2 earnings, with a focus on its Analytical Instruments segment, indicating potential positive performance in this area.
• The bullish approach adopted by deep-pocketed investors towards TMO, as reflected in the options market, could be driving the upward momentum in the stock price.
• The market seems optimistic about Thermo Fisher's growth prospects, especially with new technological launches in key segments, fueling investor confidence and contributing to the bullish movement in the stock today.

10.06.2025 - TMO Stock was up 4.6%

• Despite negative moves by financial institutions and stock downgrades by analysts, Thermo Fisher Scientific (TMO) saw a significant rise in stock price.
• Unusual options trading, displaying a mix of bullish and bearish trends, likely contributed to the stock's fluctuating price.
• Divergent opinions among traders and analysts may have caused market uncertainty, prompting increased buying activity and driving up the stock price.
• Investors possibly prioritized the company's strong fundamentals and future growth potential, overshadowing short-term bearish signals from analysts and options trades.

10.05.2025 - TMO Stock was up 3.3%

• The recent increase in TMO's stock price may be linked to the following factors:
• Investors' positive response to the 1.27% rise in TMO's price during the current market session, despite the recent downward trend.
• Possible renewed market optimism regarding TMO's future growth opportunities or potential positive developments within the company.
• The overall favorable market or sector sentiment may have buoyed TMO and other stocks, contributing to today's bullish movement.

01.09.2025 - TMO Stock was up 9.2%

• The stock of Thermo Fisher Scientific showed a strong upward trend today, likely influenced by a noteworthy Power Inflow alert, reflecting optimistic sentiment from institutional and retail investors.
• The company's decision to initiate a four-part bond offering in anticipation of a potential government shutdown might have also played a part in the positive trend, demonstrating proactive financial preparation and stability.
• The optimistic actions of financial institutions and the prevailing bullish sentiment among traders regarding TMO all contributed to the favorable momentum, underscoring confidence in the company's future prospects.